Fonte: Frontiers in immunology. Unidades: FM, ICB, BIOINFORMÁTICA
Assuntos: TRANSPLANTE DE TECIDOS, TERAPIA BIOLÓGICA, COVID-19, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTO, Pedro Silva et al. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery. Frontiers in immunology, v. 14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55966. Acesso em: 02 nov. 2024.APA
Couto, P. S., Al-Arawe, N., Filgueiras, I. S., Fonseca, D. L. M. da, Hinterseher, I., Catar, R. A., et al. (2023). Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery. Frontiers in immunology, 14. doi:10.3389/fimmu.2023.1200180NLM
Couto PS, Al-Arawe N, Filgueiras IS, Fonseca DLM da, Hinterseher I, Catar RA, Chinnadurai R, Bersenev A, Marques OC, Moll G, Verter F. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery [Internet]. Frontiers in immunology. 2023 ; 14[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55966Vancouver
Couto PS, Al-Arawe N, Filgueiras IS, Fonseca DLM da, Hinterseher I, Catar RA, Chinnadurai R, Bersenev A, Marques OC, Moll G, Verter F. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery [Internet]. Frontiers in immunology. 2023 ; 14[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55966